Proliferating cell nuclear antigen (PCNA) in cerebral cavernomas: An immunocytochemical study of 42 cases

Surgical Neurology

Volumn 47, Issue 4, 1997, Pages 364-370

  Notelet, L ^a   Houtteville, J P ^a   Khoury, S ^a   Lechevalier, B ^a   Chapon, F ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Cerebral cavernous angiomas; endothelial cells; proliferating cell nuclear antigen (PCNA)

Indexed keywords

CYCLINE;

ADOLESCENT; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CAVERNOUS HEMANGIOMA; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; CHILD; FEMALE; HEMANGIOMA, CAVERNOUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0030987863     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(96)00248-0     Document Type: Article

References (34)

1. Allegranza A, Girlando S, Arrigoni GL, Veronese S, Mauri FA, Gambacorta M, Pollo B, Dalla Palma P, Barbareschi M. Proliferating cell nuclear antigen expression in central nervous system neoplasms. Virchows Archiv [A] 1991;419:417-23.
2. Bertalanffy H, Kühn G, Scheremet R, Seeger W. Indications for surgery and prognosis in patients with cerebral cavernous angiomas. Neurol Med Chir (Tokyo) 1992;32:659-66.
3. Celis JE, Bravo R, Mose Larsen P, Fey SJ. Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leuk Res 1984;8:143-57.
4. Chapon F, Lechevalier B, Caruelle D, Khoury S, Houtteville JP. PCNA and FGF in cerebral cavernomas: comparison with pathological data and clinical evolution: preliminary results. Arch Neurobiol (Spain) 1991;54:245 (abst).
5. Gerritsen ME, Bloor CM. Endothelial cell gene expression in response to injury. FASEB J 1993;7:523-32.
6. Hall PA, Levison DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-94.
7. Hall PA, Woods AL. Immunohistochemical markers of cellular proliferation: achievements, problems and prospects. Cell Tissue Kinet 1990;23:505-22.
8. Khoury S. Les cavernomes cérébraux: étude d'une série de 37 cas. Caen: Thèse de Médecine de l'Université de Caen, 1991.
9. Kim DK, Hoyt J, Bacchi C, Evren Keles G, Mass M, Mayberg MR, Berger MS. Detection of proliferating cell nuclear antigen in gliomas and adjacent resection margins. Neurosurgery 1993;33:619-26.
10. Klagsbrun M, D'Amore PA. Regulators of angiogenesis. Annual Rev Physiol 1991;53:217-39.
11. Kousseff BG. The phakomatoses as paracrine growth disorders (paracrinopathies). Clin Genet 1990;37:97-105.
12. Lechevalier B, Houtteville JP. Cavernomes intracrâniens. Rev Neurol (Paris) 1992;148:173-9.
13. Leu HJ. Pathomorphology of vascular malformations. Int Angiol 1990;9:147-54.
14. Lindsay-Williams R, Risau W, Zerwes H-G, Drexler H, Aguzzi A, Wagner EF. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell 1989;57:1053-63.
15. Mazza C, Scienza R, Beltramello A, Da Pian R. Cerebral cavernous malformations (cavernomas) in the pediatric age-group. Childs Nerv Syst 1991;7:139-46.
16. Otten P, Pizzolato GP, Rilliet B, Berney J. A propos de 131 cas d'angiomes caverneux (cavernomes) du S.N.C. repérés par l'analyse rétrospective de 24 535 autopsies. Neurochirurgie (Paris) 1989;35:82-3.
17. Polverini PJ. A genetic link in the control of angiogenesis. In: Rabes H, Peters PE, Munk K, eds. Metastasis: basic research and its clinical applications. Contributions to Oncology Basel: Karger, 1992;44:232-41.
18. Pozzati E, Giuliani G, Nuzzo G, Poppi M. The growth of cerebral cavernous angiomas. Neurosurgery 1989;25: 92-7.
19. Requena I, Arias M, Lòpez-Ibor L, Pereiro I, Barba A, Alonso A, Montòn E. Cavernomas of the central nervous system: clinical and neuroimaging manifestations in 47 patients. J Neurol Neurosurg Psychiatry 1991;54:590-4.
20. Rigamonti D, Johnson PC, Spetzler RF, Hadley MN, Drayer BP. Cavernous malformations and capillary telangiectasia: a spectrum within a single pathological entity. Neurosurgery 1991;28:60-4.
21. Risau W. Vasculogenesis, angiogenesis and endothelial cell differentiation during embryonic development. In: Feinberg RN, Sherer GK, Auerbach R, eds. The development of the vascular system. Basel: Karger, 1991;14:58-68.
22. Robinson JR, Awad IA, Little JR. Natural history of the cavernous angioma. J Neurosurg 1991;75:709-14.
23. Russell DS, Rubinstein LJ. Pathology of tumours of the central nervous system. Fifth edition. London: Arnold 1989:727-65.
24. Schiffer D, Chiò A, Giordana MT, Pezzulo T, Vigliani MC. Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: an immunohistochemical study. Acta Neuropathol (Berl) 1993;85:495-502.
25. Scott RM, Barnes P, Kupsky W, Adelman LS. Cavernous angiomas of the central nervous system in children. J Neurosurg 1992;76:38-46.
26. Sigal R, Halimi P, Doyon D, Blas C, Chan KY. Imagerie des cavernomes de l'encéphale: tomodensitométrie et imagerie par résonance magnétique. Neurochirurgie (Paris) 1989;35:89-94.
27. Simard JM, Garcia-Bengochea F, Ballinger WE, Parker Mickle J, Quisling RG. Cavernous angioma: a review of 126 collected and 12 new clinical cases. Neurosurgery 1986;18:162-72.
28. Steiger HJ, Markwalder RV, Reulen HJ. Y a-t-il une relation entre manifestation clinique et l'image pathologique des cavernomes cerebraux? Neurochirurgie (Paris) 1989;35:84-8.
29. Takahashi K, Mulliken JB, Kozakewich HPW, Rogers RA, Folkman J, Ezekowitz RAB. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994;93:2357-64.
30. Turjman F, Arteaga C, Tavernier T, Bossard D, Bochu M, Jouvet A, Froment JC. Haemorrhagic complications of intracerebral cavernomas: value of MRI. J Neuroradiol 1992;19:107-17.
31. Voigt K, Yasargil MG. Cerebral cavernous haemangiomas or cavernomas: incidence, pathology, localization, diagnosis, clinical features and treatment. Review of the literature and report of an unusual case. Neurochirurgia (Stuttg) 1976;19:59-68.
32. Weber M, Vespignani H, Bracard S, Roland J, Picard L, Barroche G, Auque J, Lepoire J. Les angiomes caverneux intracérébraux. Rev Neurol (Paris) 1989;145: 429-36.
33. Wolf HK, Dittrich KL. Detection of proliferating cell nuclear antigen in diagnostic histopathology. J Histochem Cytochem 1992;40:1269-73.
34. Zabramski JM, Wascher TM, Spetzler RF, Johnson B, Golfinos J, Drayer BP, Brown B, Rigamonti D, Brown G. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 1994;80:422-32.